HCTI / Healthcare Triangle, Inc. - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 29, 20

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 29, 2025 (June 16, 2025) HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other juri

UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION

Exhibit 99.3 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION The unaudited pro forma condensed combined financial data should be read in conjunction with the historical financial statements and the accompanying notes of Healthcare Triangle, Inc. included in its Annual Report on Form 10-K filed with the Securities and Exchange Commission (SEC) on March 30, 2025 and Quarterly Reports on

AUDITED FINANCIAL STATEMENTS OF EZOVION SOLUTIONS PRIVATE LIMITED AS OF DECEMBER 31, 2024 AND 2023 AND FOR THE YEARS ENDED DECEMBER 31, 2024 AND 2023

Exhibit 99.2

AUDITED FINANCIAL STATEMENTS OF NIYAMA HEALTHCARE, INC. AS OF DECEMBER 31, 2024 AND 2023 AND FOR THE YEARS ENDED DECEMBER 31, 2024 AND 2023

Exhibit 99.1

AMENDMENT NO. 1 TO ASSET TRANSFER AGREEMENT

Exhibit 10.1 AMENDMENT NO. 1 TO ASSET TRANSFER AGREEMENT This Amendment No. 1 (the “Amendment) dated as of August 28, 2025 is entered into among Niyama Healthcare, Inc., a Delaware corporation (the “Seller”), and Healthcare Triangle, Inc., a Delaware corporation (the “Purchaser). Seller, and the Purchaser are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 ☐ TRANSITION REPORT PURSUANT TO S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40903 HEALTHCARE TRIANGLE, INC.

Certificate of Amendment to Certificate of Incorporation of Healthcare Triangle, Inc.

Exhibit 3.1 CERTIFICATE OF AMENDMENT TO THE CERTIFICATE OF INCORPORATION OF HEALTHCARE TRIANGLE, INC. Healthcare Triangle, Inc. (the “Corporation”), a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the “DGCL”), does hereby certify: 1. Pursuant to Section 242 of the DGCL, this Certificate of Amendment to the Amended Certificate of Inc

Certificate of Correction to Certificate of Amendment to Certificate of Incorporation of Healthcare Triangle, Inc.

Exhibit 3.2 CERTIFICATE OF CORRECTION TO THE CERTIFICATE OF AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF HEALTHCARE TRIANGLE, INC. Healthcare Triangle, Inc. (the “Corporation”), a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the “DGCL”), does hereby certify: 1. The name of the corporation is Healthcare Tria

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 30, 2025 HEALTHCARE TRIANGLE,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 30, 2025 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commission

Healthcare Triangle, Inc. Announces 1-for-249 Reverse Stock Split as Part of Nasdaq Compliance Plan

Exhibit 99.1 Healthcare Triangle, Inc. Announces 1-for-249 Reverse Stock Split as Part of Nasdaq Compliance Plan PLEASANTON, Calif., July 30, 2025 (GLOBENEWSWIRE) - Healthcare Triangle, Inc. (Nasdaq: HCTI) (“HCTI” or the “Company”), a leader in digital transformation solutions including managed services, cloud enablement, and data analytics for the healthcare and life sciences industry, today anno

Healthcare Triangle, Inc. Announces Nasdaq Hearings Panel’s Grant of the Company’s Request for Continued Listing of its Securities.

Exhibit 99.1 Healthcare Triangle, Inc. Announces Nasdaq Hearings Panel’s Grant of the Company’s Request for Continued Listing of its Securities. Pleasanton, California, July 7, 2025. (NewsMediaWire) - Healthcare Triangle, Inc. (Nasdaq: HCTI) (“HCTI” or the “Company”), a visionary leader in digital transformation solutions for the healthcare and life sciences industries, today announced today annou

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 2, 2025 HEALTHCARE TRIANGLE,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 2, 2025 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commission F

Healthcare Triangle Completes Strategic Acquisition of Niyama Healthcare and Ezovion Solutions

Exhibit 99.1 Healthcare Triangle Completes Strategic Acquisition of Niyama Healthcare and Ezovion Solutions Pleasanton, California, June 16, 2025. (NewMediaWire) - Healthcare Triangle, Inc. (Nasdaq: HCTI) (“HCTI” or the "Company"), a visionary leader in digital transformation solutions for the healthcare and life sciences industries, today announced the successful closing of its acquisition of the

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 16, 2025 HEALTHCARE TRIANGLE,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 16, 2025 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commission

Asset and Stock Transfer Agreement, dated June 16, 2025, by and amongHealthcare Triangle, Inc., through its wholly owned subsidiary QuantumNexis Inc., and Niyama Healthcare, Inc,.

Exhibit 10.1 ASSET and STOCK TRANSFER AGREEMENT June 16, 2025 ASSET TRANSFER AGREEMENT This ASSET and STOCK TRANSFER AGREEMENT (the “Agreement”) is entered into as of June 16, 2025 (“Execution Date”) by and between: (1) Niyama Healthcare, Inc., a Delaware corporation, having its registered office at 8 The Green, #21863, Dover, DE 19901, USA (the “Seller” which expression shall unless repugnant to

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 30, 2025 HEALTHCARE TRIANGLE,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 30, 2025 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commission F

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 20, 2025 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commission F

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 ☐ TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40903 HEALTHCARE TRIANGLE, INC

HEALTHCARE TRIANGLE, INC. Up to 1,483,809,885 Shares of Common Stock

Filed Pursuant to Rule 424(b)(4) Registration No. 333-286331 HEALTHCARE TRIANGLE, INC. Up to 1,483,809,885 Shares of Common Stock This prospectus relates to the offer and sale from time to time of up to 1,483,809,885 shares of common stock, par value $0.00001 per share (the “Common Stock”) of Healthcare Triangle, Inc., (either individually or together with its subsidiaries, “us, “we”, “our”, “HCTI

Healthcare Triangle, Inc. 7901 Stoneridge Drive, Suite 220 Pleasanton, CA 94588 May 13, 2025

Healthcare Triangle, Inc. 7901 Stoneridge Drive, Suite 220 Pleasanton, CA 94588 May 13, 2025 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Aliya Ishmukhamedova / Matthew Crispino Re: Healthcare Triangle, Inc. Registration Statement on Form S-1, as amended File No. 333-286331 Ladies and Gentlemen: Purs

Healthcare Triangle, Inc. 7901 Stoneridge Drive, Suite 220 Pleasanton, CA 94588

Healthcare Triangle, Inc. 7901 Stoneridge Drive, Suite 220 Pleasanton, CA 94588 May 13, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Aliya Ishmukhamedova / Matthew Crispino Re: Healthcare Triangle, Inc. Registration Statement on Form S-1, as amended File No. 333-286331 Ladies and Gentlemen: Reference is

7901 Stoneridge Drive, Suite 220 Pleasanton, CA 94588

Healthcare Triangle, Inc. 7901 Stoneridge Drive, Suite 220 Pleasanton, CA 94588 May 13, 2025 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Aliya Ishmukhamedova / Matthew Crispino Re: Healthcare Triangle, Inc. Registration Statement on Form S-1, as amended File No. 333-286331 Ladies and Gentlemen: Purs

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form N-SAR ☐ Form N-CSR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form N-SAR ☐ Form N-CSR For Period Ended: 3/31/2025 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Report on Form N-SAR For the Transition Period Ended: n/a Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

As filed with the Securities and Exchange Commission on May 8, 2025

As filed with the Securities and Exchange Commission on May 8, 2025 Registration No.

* * * * *

May 8, 2025 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Technology 100 F. Street, NE Washington, D.C. 20549 Attention: Aliya Ishmukhamedova / Matthew Crispino Re: Healthcare Triangle, Inc. Amendment No. 2 to Registration Statement on Form S-1 Originally Submitted on April 1, 2025 File No. 333-286331 Ladies and Gentlemen: On behalf of Healthcare Trian

As filed with the Securities and Exchange Commission on April 22, 2025

As filed with the Securities and Exchange Commission on April 22, 2025 Registration No.

* * * * *

April 22, 2025 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Technology 100 F. Street, NE Washington, D.C. 20549 Attention: Aliya Ishmukhamedova / Matthew Crispino Re: Healthcare Triangle, Inc. Amendment No. 1 to Registration Statement on Form S-1 Submitted April 1, 2025 File No. 333-286331 Ladies and Gentlemen: On behalf of Healthcare Triangle, Inc. (

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 8, 2025 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commission

Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 10, 2025 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commission

Healthcare Triangle announces the appointment of Chief Financial Officer and Director on the Board.

Exhibit 99.1 Healthcare Triangle announces the appointment of Chief Financial Officer and Director on the Board. PLEASANTON, Calif., April 11th , 2025 (NEWMEDIAWIRE) - Healthcare Triangle, Inc (Nasdaq: HCTI) (“HCTI” or the “Company”), a leader in digital transformation solutions including managed services, cloud enablement, cybersecurity, data analytics, and AI for the healthcare and life sciences

Letter from M&K CPAS, PLLC (incorporated by reference to Exhibit 16.1 to the Company’s current report on Form 8-K, filed with the SEC on April 11, 2025)

Exhibit 16.1 April 11, 2025 Securities and Exchange Commission Office of the Chief Accountant 100 F Street N.E. Washington, D.C. 20549 Re: Healthcare Triangle, Inc. File Ref. No. 001-40903 We have read the statements made by Healthcare Triangle, Inc., which we understand will be filed by the Commission, pursuant to Item 4.01 of Form 8-K, as part of Healthcare Triangle, Inc. Form 8-K report dated A

Employment Agreement between Healthcare Triangle, Inc. and Mr. David Ayanoglou, dated April 10, 2025. (incorporated by reference to Exhibit 10.1 to the Company’s current report on Form 8-K, filed with the SEC on April 11, 2025)

Exhibit 10.1 Employment Agreement THIS EMPLOYMENT AGREEMENT (this “Agreement”) by and between HEALTHCARE TRIANGLE INC. a Delaware limited liability company (the “Company”) and DAVID AYANOGLOU (the “Employee”) is signed by the Company and the Employee on 10th April 2025 (the “Effective Date”). Background The Board of Directors of the Company (the “Board”) has determined that it is in the best inter

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 28, 2025 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commission

Exhibit Filing Fees

Exhibit 107 Calculation of Filing Fee Tables Form S-1 (Form Type) Healthcare Triangle, Inc.

As filed with the Securities and Exchange Commission on April 1, 2025

As filed with the Securities and Exchange Commission on April 1, 2025 Registration No.

Description of Securities

Exhibit 4.4 DESCRIPTION OF CAPITAL STOCK General The following description summarizes the most important terms of our capital stock. Because it is only a summary, it does not contain all the information that may be important to you. For a complete description of the matters set forth in this “Description of Capital Stock,” you should refer to our amended and restated certificate of incorporation,

HCTI - Convertible Unsecured Promissory Note, dated October 09, 2025 (incorporated by reference to Exhibit 4.5 to the Company’s Annual Report on Form 10-K, filed with the SEC on March 31, 2025)

Exhibit 4.5 THIS NOTE HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABL

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 ☐ TRANSITION REPORT PURSUA

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number: 001-40903 HEALTHCARE TRIANG

Healthcare Triangle announces the appointment of Chief Operating Officer

Exhibit 99.1 Healthcare Triangle announces the appointment of Chief Operating Officer PLEASANTON, Calif., March 18, 2025 (GLOBENEWSWIRE) - Healthcare Triangle, Inc (Nasdaq: HCTI) (“HCTI” or the “Company”), a leader in digital transformation solutions including managed services, cloud enablement, cybersecurity, data analytics, and AI for the healthcare and life sciences industries, today announced

Employment Agreement between Healthcare Triangle, Inc. and Ms. Sujatha Ramesh, dated March 18, 2025. (incorporated by reference to Exhibit 10.1 to the Company’s current report on Form 8-K, filed with the SEC on March 24, 2025)

Exhibit 10.1 Employment Agreement THIS EMPLOYMENT AGREEMENT (this “Agreement”) by and between HEALTHCARE TRIANGLE INC. a Delaware limited liability company (the “Company”) and SUJATHA RAMESH (the “Employee”) is signed by the Company and the Employee on March 18, 2025 (the “Effective Date”). Background The Board of Directors of the Company (the “Board”) has determined that it is in the best interes

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 18, 2025 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commission

Schedule 14C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C (Rule 14c-101) INFORMATION REQUIRED IN INFORMATION STATEMENT SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 (Amendment No. ) Check the appropriate box: ☐ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted b

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defin

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C (Rule 14c-101) Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C (Rule 14c-101) Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 (Amendment No. ) ☒ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ☐ Definitive Information Statement HEALTHCARE TRIANGLE, INC. (Name of Registra

Form of Securities Purchase Agreement (incorporated by reference to Exhibit 10.1 to the Company’s current report on Form 8-K, filed with the SEC on February 28, 2025)

Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of February 27, 2025, between Healthcare Triangle, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (including their respective successors and assigns, each a “Purchaser” and collectively, the “Purchasers”). WHEREAS, subject to the te

Healthcare Triangle, Inc Announces $15.2 Million PIPE Offering.

Exhibit 99.1 Healthcare Triangle, Inc Announces $15.2 Million PIPE Offering. Healthcare Triangle, Inc (NASDAQ: HCTI) (“HCTI” or the “Company”), PLEASANTON, Calif., February 27, 2025 (GLOBENEWSWIRE) - Healthcare Triangle, Inc. (Nasdaq: HCTI) (“HCTI” or the “Company”), a leader in digital transformation solutions including managed services, cloud enablement, cybersecurity, and data analytics for the

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 27, 2025 HEALTHCARE TRIAN

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 27, 2025 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commiss

Form of Series A Warrant (incorporated by reference to Exhibit 4.1 to the Company’s current report on Form 8-K, filed with the SEC on February 28, 2025)

Exhibit 4.1 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR T

Healthcare Triangle, Inc Announces Closing of $15.2 Million PIPE Offering

Exhibit 99.2 Healthcare Triangle, Inc Announces Closing of $15.2 Million PIPE Offering PLEASANTON, CA - February 28, 2025 (NEWMEDIAWIRE) - Healthcare Triangle, Inc (NASDAQ: HCTI) (“HCTI” or the “Company”), a leader in digital transformation solutions, including managed services, cloud enablement, cybersecurity, and data analytics for the healthcare and life sciences industries, today announced the

Form of Series B Warrant (incorporated by reference to Exhibit 4.2 to the Company’s current report on Form 8-K, filed with the SEC on February 28, 2025)

Exhibit 4.2 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR T

Registration Rights Agreement (incorporated by reference to Exhibit 10.2 to the Company’s current report on Form 8-K, filed with the SEC on February 28, 2025)

Exhibit 10.2 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this “Agreement”) is made and entered into as of February 27, 2025, between Healthcare Triangle, Inc., a Delaware corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”). This Agreement is made pursuant to the Securities Pu

Form of Pre-Funded Warrant (incorporated by reference to Exhibit 4.3 to the Company’s current report on Form 8-K, filed with the SEC on February 28, 2025)

Exhibit 4.3 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 26, 2025 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commiss

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State

Letter of M&K CPAS, PLLC dated February 14, 2025

Exhibit 16.1 February 14, 2025 Securities and Exchange Commission 100 F Street NE Washington, DC 20549 Ladies and Gentlemen: We have read the statements made by Healthcare Triangle, Inc. (the “Company”), set forth in Item 4.02 of the Company’s Current Report on Form 8-K, dated February 14, 2025 (the “Form 8-K”). We agree with the statements concerning our Firm contained in such Item 4.02. Very tru

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Amendment No. 1) (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSI

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Amendment No. 1) (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number: 001-40903

Description of Securities

Exhibit 4.4 HEALTHCARE TRIANGLE, INC. DESCRIPTION OF SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED The following is a description of the common stock of Healthcare Triangle, Inc. (the “Company,” “we,” “our,” or “us”), which is the only security of the Company registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (the

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 12, 2025 HEALTHCARE TRIA

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 12, 2025 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commis

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 14, 2025 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commissi

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 4, 2024 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commissi

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 21, 2024 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of inco

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40903 HEALTHCARE TRIANGLE,

Asset Transfer Agreement, by and between Healthcare Triangle, Inc. and SecureKloud Technologies, Inc., dated October 21, 2024 (incorporated by reference to Exhibit 10.1 to the Company’s current report on Form 8-K, filed with the SEC on October 25, 2024)

Exhibit 10.1 ASSET TRANSFER AGREEMENT October 21, 2024 ASSET TRANSFER AGREEMENT This ASSET TRANSFER AGREEMENT (the “Agreement”) is entered into as of October 21, 2024 (“Execution Date”) by and between: (1) SecureKloud Technologies, Inc ., a Nevada corporation, having its registered office at 666 Plainsboro Road, Suite 448, Plainsboro, NJ 08536, USA (the “Seller” which expression shall unless repug

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 21, 2024 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commissi

Certificate of Designations of Preferences, Rights and Limitations of Series B Convertible Preferred Stock, dated October 22, 2024 (incorporated by reference to Exhibit 3.1 to the Company’s current report on Form 8-K, filed with the SEC on October 25, 2024)

Exhibit 3.1 HEALTHCARE TRIANGLE, INC. CERTIFICATE OF DESIGNATIONS, RIGHTS AND PREFERENCES OF SERIES B CONVERTIBLE PREFERRED STOCK Pursuant to Section 151 of the Delaware General Corporation Law, Healthcare Triangle, Inc., a Delaware corporation (the “Corporation”), DOES HEREBY CERTIFY: WHEREAS, the Amended and Restated Certificate of Incorporation of the Corporation, as amended (the “Certificate o

Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 4, 2024 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commiss

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 3, 2024 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commiss

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14C Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14C Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 (Amendment No. ) Check the appropriate box: ☒ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ☐ Definitive Information Statement HEALTHCARE TRIANGLE, INC. (Name

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 ☐ TRANSITION REPORT PURSUANT TO S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40903 HEALTHCARE TRIANGLE, INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form N-SAR ☐ Form N-CSR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form N-SAR ☐ Form N-CSR For Period Ended: 6/30/2024 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Report on Form N-SAR For the Transition Period Ended: n/a Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 26, 2024 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commission

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40903 HEALTHCARE TRIANGLE, INC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form N-SAR ☐ Form N-CSR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form N-SAR ☐ Form N-CSR For Period Ended: 3/31/2024 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Report on Form N-SAR For the Transition Period Ended: n/a Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 8, 2024 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commission Fi

Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 3, 2024 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commission Fi

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 20, 2024 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commission

Healthcare Triangle, Inc. Appoints Anand Kumar as Interim CEO

Exhibit 99.1 Healthcare Triangle, Inc. Appoints Anand Kumar as Interim CEO PLEASANTON, Calif., March 12, 2024 - Healthcare Triangle Inc. (Nasdaq: HCTI) (“Healthcare Triangle,” “HCTI” or the “Company”), a frontrunner in healthcare technology has announced the appointment of Anand Kumar as the interim Chief Executive Officer alongside his current role as the Chief Revenue Officer. Anand is committed

Description of Securities

Exhibit 4.4 HEALTHCARE TRIANGLE, INC. DESCRIPTION OF SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED The following is a description of the common stock of Healthcare Triangle, Inc. (the “Company,” “we,” “our,” or “us”), which is the only security of the Company registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (the

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 12, 2024 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commission

Offer Letter, dated March 14, 2024, between Healthcare Triangle, Inc. and Anand Kumar.

Exhibit 10.1 3/14/2024 Anand Kumar Healthcare Triangle, Inc. (HCTI) is pleased to offer you the role of interim CEO. Itemized below are the proposed terms of our offer: 1. As interim CEO and a full time, permanent employee, your base salary will be $240,000 per year. 2. As a full time, permanent employee, you will be entitled to participate in our Unlimited Vacation Policy. You are also entitled t

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUA

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number: 001-40903 HEALTHCARE TRIANG

Healthcare Triangle, Inc. 7901 Stoneridge Drive, Suite 220 Pleasanton, CA 94588 February 13, 2024

Healthcare Triangle, Inc. 7901 Stoneridge Drive, Suite 220 Pleasanton, CA 94588 February 13, 2024 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Ms. Charli Gibbs-Tabler/Matthew Derby Re: Healthcare Triangle, Inc. Registration Statement on Form S-1, as amended File No. 333-276501 Ladies and Gentlemen: P

As filed with the Securities and Exchange Commission on February 12, 2024

As filed with the Securities and Exchange Commission on February 12, 2024 Registration No.

* * * * *

February 9, 2024 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Manufacturing 100 F. Street, NE Washington, D.C. 20549 Attention: Charli Gibbs-Tabler / Matthew Derby Re: Healthcare Triangle, Inc. Amendment No. 1 to Registration Statement on Form S-1 Submitted January 12, 2024 CIK No. 0001839285 Ladies and Gentlemen: On behalf of Healthcare Triangle, Inc

As filed with the Securities and Exchange Commission on February 9, 2024

As filed with the Securities and Exchange Commission on February 9, 2024 Registration No.

Supplier Master Services Agreement, dated as of August 10, 2021, by and between Guidant Global, Inc., and Devcool, Inc.

Exhibit 10.23

January 30, 2024

Exhibit 99.1 January 30, 2024 Devcool Inc 5890 Stoneridge Dr #107 Pleasanton, CA 94588 RE: Termination of Staffing Company Agreement between Guidant Global, Inc. and Devcool Inc Dear Supplier: The purpose of this letter is to provide Devcool Inc (“Supplier”) with notice of Guidant Global Inc.’s (“Guidant”) termination of the Supplier Master Services Agreement entered into between Guidant and Suppl

Termination of a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 30, 2024 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commissi

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 1, 2024 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction (Commission File Number) (I

February 1, 2024

Exhibit 99.1 February 1, 2024 To Dave Rosa Chairman of the Board Healthcare Triangle, Inc. 7901 Stoneridge Drive, Suite # 220, Pleasanton CA, USA 94588 Dear Dave, I would like to notify you and the rest of the Board that I have decided to step down from the Board of Director position with Healthcare Triangle, Inc. effective February 01st 2024 due to personal time commitments. Thank you for all the

Healthcare Triangle, Inc. 7901 Stoneridge Drive, Suite 220 Pleasanton, CA 94588

Healthcare Triangle, Inc. 7901 Stoneridge Drive, Suite 220 Pleasanton, CA 94588 January 29, 2024 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Ms. Charli Gibbs-Tabler Re: Healthcare Triangle, Inc. Request for Acceleration Registration Statement on Form S-3 File No. 333-276382 Ladies and Gentlemen: Pursuant to

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C (Rule 14c-101) SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 (Amendment No. ____)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C (Rule 14c-101) SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 (Amendment No. ) Check the appropriate box: ☐ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ☒ Definitive Information S

Form of Senior Indenture

Exhibit 4.2 HEALTHCARE TRIANGLE, INC. as the Company and as Trustee Senior Indenture Dated as of , 20 1 TABLE OF CONTENTS PAGE ARTICLE 1 DEFINITIONS AND INCORPORATION BY REFERENCE 5 Section 1.01. Definitions 5 Section 1.02. Other Definitions 9 Section 1.03. Incorporation by Reference of Trust Indenture Act 9 Section 1.04. Rules of Construction 10 ARTICLE 2 THE SECURITIES 10 Section 2.01. Form and

As filed with the Securities and Exchange Commission on January 16, 2024

As filed with the Securities and Exchange Commission on January 16, 2024 Registration No.

Form of Subordinated Indenture

Exhibit 4.3 HEALTHCARE TRIANGLE, INC. as the Company and as Trustee Subordinated Indenture Dated as of , 20 TABLE OF CONTENTS PAGE ARTICLE 1 DEFINITIONS AND INCORPORATION BY REFERENCE 4 Section 1.01. Definitions 4 Section 1.02. Other Definitions 8 Section 1.03. Incorporation by Reference of Trust Indenture Act 8 Section 1.04. Rules of Construction 8 ARTICLE 2 THE SECURITIES 9 Section 2.01. Form an

Exhibit Filing Fees

Exhibit 107 Calculation of Filing Fee Tables FORM S-1 (Form Type) HEALTHCARE TRIANGLE, INC.

As filed with the Securities and Exchange Commission on January 12, 2024

As filed with the Securities and Exchange Commission on January 12, 2024 Registration No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 12, 2

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 12, 2024 (December 28, 2023) HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other

Form of Senior Secured 15% Original Issue Discount Convertible Promissory Note.*

Exhibit 4.1 THIS NOTE HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABL

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C (Rule 14c-101) SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 (Amendment No. ____)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C (Rule 14c-101) SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 (Amendment No. ) Check the appropriate box: ☒ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ☐ Definitive Information S

As filed with the Securities and Exchange Commission on January 4, 2024

As filed with the Securities and Exchange Commission on January 4, 2024 Registration No.

Exhibit Filing Fees

Calculation of Filing Fee Tables S-3 (Form Type) Healthcare Triangle, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered(1) Proposed Maximum Offering Price Per Share (2) Maximum Aggregate Offering Price( Fee Rate Amount of Registration Fee Fees

ATM Sales Agreement, dated January 4, 2024 between the Registrant and Dawson James Securities, Inc.

HEALTHCARE TRIANGLE, INC. COMMON STOCK ATM SALES AGREEMENT January 4, 2024 Dawson James Securities, Inc. 101 North Federal Highway Suite 600 Boca Raton, Fl 33432 Ladies and Gentlemen: Healthcare Triangle, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Dawson James Securities, Inc., as follows: 1. Issuance and Sale of Shares. The Company agrees that, fr

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A (Amendment No. 1) (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ☐ TRAN

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A (Amendment No. 1) (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number: 001-409

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 28, 2023 HEALTHCARE TRIAN

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 28, 2023 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commiss

Security Agreement, dated as of December 28, 2023, by and between the Company, Devcool, and the Investor (incorporated by reference to

SECURITY AGREEMENT THIS SECURITY AGREEMENT (as amended, restated, supplemented or otherwise modified from time to time, this “Agreement”) dated as of December 28, 2023, between Healthcare Triangle, Inc.

Form of Common Stock Purchase Warrant (incorporated by reference to Exhibit 4.2 to the Company’s current report on Form 8-K, filed

NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEM

Healthcare Triangle, Inc. Completes $2.0 Million Private Placement Debt Offering

Healthcare Triangle, Inc. Completes $2.0 Million Private Placement Debt Offering PLEASANTON, Calif., January 2, 2024 (GLOBENEWSWIRE) - Healthcare Triangle, Inc. (Nasdaq: HCTI) (“Healthcare Triangle,” “HCTI” or the “Company”), a leader in digital transformation solutions including managed services, cloud enablement, cybersecurity, data analytics, and AI data processing for the healthcare and life s

Subsidiary Guarantee, dated as of December 28, 2023, by and between the Company, Devcool, and the Investor (incorporated by reference

FORM OF SUBSIDIARY GUARANTEE This SUBSIDIARY GUARANTEE (as amended, restated, supplemented, or otherwise modified and in effect from time to time, this “Guarantee”) is made as of December 28, 2023, jointly and severally, between Healthcare Triangle, Inc.

Form of Securities Purchase Agreement, dated as of December 28, 2023, by and between the Company and the Investor (incorporated by

SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of December 28, 2023, between Healthcare Triangle, Inc.

Intercreditor Agreement, dated as of December 28, 2023, by and between Seacoast National Bank and the Investor (incorporated by

INTERCREDITOR AGREEMENT THIS AGREEMENT made and entered into this 28th day of December 2023 by and among SEACOAST BUSINESS FUNDING, a division of Seacoast National Bank with a place of business at 1880 N Congress Ave.

Form of Registration Rights Agreement, dated as of December 28, 2023, by and between the Company and the Investor (incorporated by

REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (the “Agreement”) is dated as of December 28, 2023, by and among Healthcare Triangle, Inc.

Pledge Agreement, dated as of December 28, 2023, by and between the Company and the Investor (incorporated by reference to Exhibit

PLEDGE AGREEMENT THIS PLEDGE AGREEMENT made as of December 28, 2023 (as amended, restated, supplemented or otherwise modified from time to time, this “Agreement”), by Healthcare Triangle, Inc.

Form of Senior Secured 15% Original Issue Discount Convertible Promissory Note (incorporated by reference to Exhibit 4.1 to the

THIS NOTE HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR UPON RECEIPT BY THE COMPANY OF AN OPINION OF COUNSEL ACCEPTABLE TO THE COMPANY THAT REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 29, 2023 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commiss

Healthcare Triangle, Inc. Clawback Policy, effective November 29, 2023 (incorporated by reference to Exhibit 10.1 to the Company’s current report on Form 8-K, filed with the SEC on November 29, 2023)

HEALTHCARE TRIANGLE, INC. CLAWBACK POLICY Introduction The Board of Directors (“Board”) of Healthcare Triangle, Inc. (the “Company”) believes that it is in the best interests of the Company and its shareholders to adopt this policy which provides for the recoupment of certain executive compensation in the event of an accounting restatement resulting from material noncompliance with financial repor

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 1)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 1) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40903 HEALTHCARE TRIANGLE,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defin

Consulting Agreement between the Company and Paige Heaphy, dated as of September 1, 2023

CONSULTING AGREEMENT THIS CONSULTING AGREEMENT (this “Agreement”) is made this September 1, 2023, to be effective upon the earlier of (1) September 1, 2023; or (2) the date their replacement is appointed as a member of the Board (which date will be the “Effective Date”), by and between Healthcare Triangle, Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 1, 2023 HEALTHCARE TRIAN

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 1, 2023 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commiss

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40903 HEALTHCARE TRIANGLE, INC.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 13, 2023 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commission

Board Agreement, dated as of July 13, 2023, by and between the Company and Dave Rosa. (incorporated by reference to Exhibit 10.1 to

Dave Rosa 9705 Emerson Court Eden Prairie, MN 55347 July 13, 2023 RE: Healthcare Triangle, Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 23, 2023 HEALTHCARE TRIANGLE,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 23, 2023 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commission

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 31, 2023 HEALTHCARE TRIANGLE,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 31, 2023 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commission F

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 25, 2023 HEALTHCARE TRIANGLE,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 25, 2023 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commission F

Certificate of Amendment to the Certificate of Incorporation of Healthcare Triangle, Inc.

CERTIFICATE OF AMENDMENT TO THE CERTIFICATE OF INCORPORATION OF HEALTHCARE TRIANGLE, INC.

Healthcare Triangle, Inc. Announces 1-for-10 Reverse Stock Split as Part of Nasdaq Compliance Plan

Healthcare Triangle, Inc. Announces 1-for-10 Reverse Stock Split as Part of Nasdaq Compliance Plan PLEASANTON, Calif., May 25, 2023 (GLOBENEWSWIRE) - Healthcare Triangle, Inc. (Nasdaq: HCTI) (“HCTI” or the "Company"), a leader in digital transformation solutions including managed services, cloud enablement, and data analytics for the healthcare and life sciences industry, today announced that it w

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40903 HEALTHCARE TRIANGLE, INC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 1, 2023 HEALTHCARE TRIANGLE,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 1, 2023 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commission

Employment Agreement, dated April 01, 2023 by and between the Company and Thyagarajan Ramachandran (incorporated by reference to

Employment Agreement THIS EMPLOYMENT AGREEMENT (this “Agreement”) by and between HEALTHCARE TRIANGLE, INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 1, 2023 HEALTHCARE TRIANGLE,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 1, 2023 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commission

Form of Securities Purchase Agreement, dated as of April 05, 2023, by and between the Company and the Purchaser (incorporated by

SECURITIES PURCHASE AGREEMENT THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”) is entered into and made effective as of April 05, 2023, by and between Healthcare Triangle Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ☐ TRANSITION REPORT PURSUA

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number: 001-40903 HEALTHCARE TRIANG

Shared Services Agreement dated January 1, 2021 between the Company and SecureKloud Technologies, Inc. (incorporated by reference to Exhibit 10.9 to the Company’s Annual Report on Form 10-K filed on March 28, 2023.)

HEALTHCARE TRIANGLE INC. SHARED SERVICES AGREEMENT This SHARED SERVICES AGREEMENT (the “Agreement”), is entered into on January 1, 2021 (the “Effective Date”), by and between Securekloud Technologies Inc., a Nevada corporation and Healthcare Triangle Inc., a Nevada corporation, (the “Company”). Securekloud Technologies Inc and the Company are hereinafter sometimes referred to collectively as the “

Master Services Agreement dated January 1, 2021 between the Company and SecureKloud Technologies, Inc. (incorporated by reference to Exhibit 10.8 to the Company’s Annual Report on Form 10-K filed on March 28, 2023.)

HEALTHCARE TRIANGLE INC. MASTER SERVICES AGREEMENT THIS Master Services Agreement (the “Agreement”) is entered into as of 01 January, 2021 (the “Effective Date”) by and between by and between Healthcare Triangle Inc., a Nevada corporation having its principal place of business 4309 Hacienda Dr, Suite 150, Pleasanton, CA 94588, (the “Company”) and Securekloud Technologies Inc., a Nevada corporation

Rental Sublease Agreement dated January 1, 2021 between SecureKloud Technologies, Inc. and the Company (incorporated by reference to Exhibit 10.10 to the Company’s Annual Report on Form 10-K filed on March 28, 2023.)

Rental Sub-Lease Agreement Securekloud Technologies, Inc. This Rental Sub-Lease Agreement (this “Sub-Lease Agreement”) is made and entered into effect as of January 1st, 2021 by and between Securekloud Technologies, Inc. (“Tenant”) and Health Care Triangle, Inc. (“Sub-Tenant”). Recitals A. Tenant and Sub-Tenant executed that certain real property sub-lease dated January 1st, 2021 (collectively, th

EX-99.2

January 5,2023 Roy Sookhoo 1504 Cereza Drive SE Rio Rancho, NM 87124 Dear Roy, Healthcare Triangle Inc.

EX-99.3

January 25, 2023 Roy Sookhoo 1504 Cereza Drive, SE Rio Rancho, NM 87124 Dear Roy, This letter will serve as an amendment to your original offer letter dated January 5, 2023.

Appointment Letter Agreement- Healthcare Triangle, Inc. Board of Directors

January 23, 2023 [New Director], Appointment Letter Agreement- Healthcare Triangle, Inc.

January 5,2023

January 5,2023 Roy Sookhoo 1504 Cereza Drive SE Rio Rancho, NM 87124 Dear Roy, Healthcare Triangle Inc.

EX-99.1

' 
9Fv“F„Ÿ # Ÿ  #Ÿ ;. L™Ÿ2fLHŒy = bLElŒbHEL‚fEs^lLHyqŸ gtRy+cLElŽbHEƒLŽƒgEtmLHyqŸ ./+")7')8; 880;  1')8 %7!2; &
") %; );,3;, ; #49-46; 2MF„Ÿ ;. L™Ÿ2fLHŒy =( AMŸ F„MŸ}nMFŠMKŸ {Ÿ MnnŸœ{“Ÿ dFŸ dMŸ -{F„KŸ {NŸ 2h„MJ{„ŠŸ dMŸ
-{F„KŸ {NŸ6MFndJF„MŸ @„hFvanM Ÿ 7vJŸ dMŸ /{r}FvœŸ dFŠŸ MnMJMKŸ {“Ÿ {ŸŠM„–MŸ FŠŸFŸ (4; -;9!; -4; *; !$5

EX-99.3

January 25, 2023 Roy Sookhoo 1504 Cereza Drive, SE Rio Rancho, NM 87124 Dear Roy, This letter will serve as an amendment to your original offer letter dated January 5, 2023.

January 25, 2023

EX-99.3 9 ex993.htm EXHIBIT 99.3 January 25, 2023 Roy Sookhoo 1504 Cereza Drive, SE Rio Rancho, NM 87124 Dear Roy, This letter will serve as an amendment to your original offer letter dated January 5, 2023. Itemized below are the proposed terms of our offer: 1. Your start date has been changed to January 25, 2023. As Chief Operating Officer and a full time, permanent employee, your base salary wil

EX-99.2

January 5,2023 Roy Sookhoo 1504 Cereza Drive SE Rio Rancho, NM 87124 Dear Roy, Healthcare Triangle Inc.

EX-99.1

' 
9Fv“F„Ÿ # Ÿ  #Ÿ ;. L™Ÿ2fLHŒy = bLElŒbHEL‚fEs^lLHyqŸ gtRy+cLElŽbHEƒLŽƒgEtmLHyqŸ ./+")7')8; 880;  1')8 %7!2; &
") %; );,3;, ; #49-46; 2MF„Ÿ ;. L™Ÿ2fLHŒy =( AMŸ F„MŸ}nMFŠMKŸ {Ÿ MnnŸœ{“Ÿ dFŸ dMŸ -{F„KŸ {NŸ 2h„MJ{„ŠŸ dMŸ
-{F„KŸ {NŸ6MFndJF„MŸ @„hFvanM Ÿ 7vJŸ dMŸ /{r}FvœŸ dFŠŸ MnMJMKŸ {“Ÿ {ŸŠM„–MŸ FŠŸFŸ (4; -;9!; -4; *; !$5

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 25, 2023 HEALTHCARE TRIANG

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 25, 2023 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commissi

Resignation Letter from Ram Associates to the Company dated December 27, 2022.

December 27, 2022 President and Board of Directors of Healthcare Triangle Inc 4309 Hacienda Dr, Suite 150 Pleasanton, CA 94588 Effective December 27, 2022, we will cease our services as your accountants.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 29, 2022 HEALTHCARE TRIAN

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 29, 2022 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commiss

Letter to the Securities and Exchange Commission from Ram Associates dated December 30, 2022.

December 30, 2022 U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 We have read the statements under Item 4.01 of the Current Report on Form 8-K of Healthcare Triangle, Inc. to be filed with the Securities and Exchange Commission on or about December 30, 2022. We agree with all statements pertaining to us. We have no basis on which to agree or disagree with the other

NASDAQ ONLINE RESOURCES

By Electronic Delivery to: [email protected]; [email protected] December 29, 2022 Mr. Thyagarajan Ramachandran Chief Financial Officer Healthcare Triangle, Inc. 7901 Stoneridge Dr., Suite 220 Pleasanton, CA 94588 Re: Healthcare Triangle, Inc. (the “Company”) Nasdaq Symbol: HCTI Dear Mr. Ramachandran: As you are aware, due to the resignations of Mr. Jeffrey S. Mathiesen, Mr. John Leo and M

EX-16.1

EX-16.2

CE RTIFIED PUBLIC ACCOUNTANTS Fl FOUNDL\TION INDEPEI-JDENTLY O\NNEO ME1v18En December 30, 2022 U.

Resignation Letter from Jeffrey S. Mathiesen dated December 23, 2022.

December 23, 2022 VIA EMAIL Board of Directors Healthcare Triangle, Inc. Dear Board members: I regret to inform you that I hereby resign from the Board of Directors and all committees of Healthcare Triangle, Inc., effectively immediately. In light of the recent developments, I have determined that I will no longer be able to effectively serve in the Board capacity and committee positions. My resig

Resignation Letter from April Bjornstad dated December 23, 2022.

December 23, 2022 VIA EMAIL Board of Directors Healthcare Triangle, Inc. Dear Board members: I regret to inform you that I hereby resign from the Board of Directors and all committees of Healthcare Triangle, Inc. effective immediately. In light of the recent developments brought to the a?en?on of the Board on December 21, 2022, I will no longer be able serve on the Board or any committees. My resi

Resignation Letter from John Leo dated December 23, 2022.

December 23, 2022 VIA EMAIL Board of Directors Healthcare Triangle, Inc. 7901 Stoneridge Drive, Suite 220 Pleasanton, CA 94588 Dear Board members: I regret to inform you that I hereby resign from the Board of Directors and all committees of Healthcare Triangle, Inc. effective immediately. In light of the recent developments brought to the attention of the Board I will no longer be able serve on th

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 19, 2022 HEALTHCARE TRIAN

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 19, 2022 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commiss

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 17, 2022 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commiss

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 ☐ TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40903 HEALTHCARE TRIANGLE,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

DEF 14A 1 hcti101422def14a.htm DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ☐ TRANSITION REPORT PURSUA

Dear Shareholders, Colleagues, Customers, and Business Partners: Thank you for your commitment and investment in Healthcare Triangle, Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin

As filed with to the Securities and Exchange Commission on August 18, 2022

As filed with to the Securities and Exchange Commission on August 18, 2022 Registration No.

Filing Fees Exhibit

EX-FILING FEES 3 ex107.htm FILING FEES TABLE Exhibit 107 Calculation of Filing Fee Tables Form S-1 (Form Type) Healthcare Triangle, Inc. (Exact Name of Registrant as Specified in its Charter) Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered(1) Proposed Maximum Offering Price Per Share Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Fee

As filed with to the Securities and Exchange Commission on August 18, 2022

As filed with to the Securities and Exchange Commission on August 18, 2022 Registration No.

Healthcare Triangle, Inc. 7901 Stoneridge Drive, Suite 220 Pleasanton, CA 94588

CORRESP 1 filename1.htm Healthcare Triangle, Inc. 7901 Stoneridge Drive, Suite 220 Pleasanton, CA 94588 August 18, 2022 VIA EDGAR U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, DC. 20549 Attn: Alexandra Barone Re: Healthcare Triangle, Inc. Registration Statement on Form S-1 File No. 333-266952 Ms. Barone: Pursuant to Rule 461 of the General Rules and Regulations under the S

LETTER

United States securities and exchange commission logo August 15, 2022 Suresh Venkatachari Chief Executive Officer Healthcare Triangle, Inc.

As confidentially submitted to the Securities and Exchange Commission on August 9, 2022

DRS 1 filename1.htm As confidentially submitted to the Securities and Exchange Commission on August 9, 2022 Registration No. 333-[ ] UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 7373 84-3559776 (State or other jurisdic

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 ☐ TRANSITION REPORT PURSUANT TO S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40903 HEALTHCARE TRIANGLE, INC.

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 10, 2022 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commission

Form of Registration Rights Agreement, dated as of July 10, 2022, by and between the Company and the Purchaser

EXHIBIT B REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this ?Agreement?) is made and entered into as of July 10, 2022, by and between Healthcare Triangle, Inc.

Form of Placement Agent Preferred Investment Option, dated July 13, 202(4)

NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS.

Pre-Funded Warrant, dated as of July 13, 2022, by and between the Company and the Purchase(4)

NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS.

Healthcare Triangle Announces Closing of $6.5 Million Private Placement

Healthcare Triangle Announces Closing of $6.5 Million Private Placement PLEASANTON, Calif., July 13, 2022 (GLOBE NEWSWIRE) ? Healthcare Triangle Inc., (Nasdaq: HCTI) (?HCTI? or the ?Company?), a leading provider of cloud and data transformation solutions for healthcare and life sciences, today announced the closing of its previously announced private placement with a single institutional investor

Healthcare Triangle Announces $6.5 Million Private Placement

Healthcare Triangle Announces $6.5 Million Private Placement PLEASANTON, Calif., July 11, 2022 (GLOBE NEWSWIRE) ? Healthcare Triangle Inc., (Nasdaq: HCTI) (?HCTI? or the ?Company?), a leading provider of cloud and data transformation solutions for healthcare and life sciences, today announced that it has entered into a definitive agreement with a single institutional investor for the issuance and

Form of Securities Purchase Agreement, dated as of July 10, 2022, by and between the Company and the Purchaser(4)

SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this ?Agreement?) is dated as of July 10, 2022, between Healthcare Triangle, Inc.

Preferred Investment Option, dated as of July 13, 2022, by and between the Company and the Purchase(4)

NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS.

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 3, 2022 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commission F

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 26, 2022 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commission F

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 ☐ TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40903 HEALTHCARE TRIANGLE, INC

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 30, 2022 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of (Commission (IRS Employer

Appointment Letter Agreement between the Company and Jeffrey S. Mathiesen, dated March 31, 2022

EX-10.1 2 ex101.htm EXHIBIT 10.1 March 31, 2022 Jeffrey S. Mathiesen 12784 Kinross Ln Naples, FL 34120 Appointment Letter Agreement – Healthcare Triangle, Inc. Board of Directors Dear Jeff: We are pleased to tell you that the Board of Directors (the “Board”) of Healthcare Triangle, Inc. (the “Company”) has elected you to serve as a member of the Board commencing from March 31, 2022. 1. Your Duties

Consulting Agreement dated December 10, 2021 between the Company and Sandeep Deokule(3)

EX-10.22 2 ex1022.htm EXHIBIT 10.22 CONSULTING AGREEMENT This CONSULTING AGREEMENT (this “Agreement”), dated as of December 10, 2021, is entered into by and between Healthcare Triangle, Inc., a Delaware corporation (the “Company”), and Mr. Sandeep Deokule, an individual and a California resident (“Consultant”). 1. Background and Purpose. Consultant and the Company are entering into this Agreement

Convertible Promissory Note, dated December 10, 2021 made to Go To Assistance Inc(3)

CONVERTIBLE PROMISSORY NOTE $2,208,840.96 December 10, 2021 FOR VALUE RECEIVED, Healthcare Triangle, Inc. a Delaware corporation, having its principal place of business at 4309 Hacienda Drive, Suite 150, Pleasanton, CA 94583 (?Buyer?), issues this CONVERTIBLE PROMISSORY NOTE (this ?Note?) to Go To Assistance Inc., a California corporation, having its principal place of business at 1217 Pineto Plac

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ☐ TRANSITION REPORT PURSUA

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number: 001-40903 HEALTHCARE TRIANG

List of Subsidiaries of the Company (Incorporated by reference to the Company’s Annual Report on Form 10-K filed on March 8, 2022.)

EX-21.1 3 ex211.htm EXHIBIT 21.2 List of Subsidiaries of the Registrant 1. Devcool, Inc.

Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 10, 2021 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation or org

DEVCOOL INC Financial Statements for the years ended December 31, 2020 and 2019

EX-99.1 2 ex991.htm EXHIBIT 99.1 DEVCOOL INC Financial Statements for the years ended December 31, 2020 and 2019 1 Report of Independent Registered Public Accounting Firm To the shareholders and the board of directors of Devcool Inc. Opinion on the Financial Statements We have audited the accompanying balance sheets of Devcool Inc (the “Company”) as of December 31, 2020 and 2019, the related state

HEALTHCARE TRIANGLE, INC. Unaudited Pro Forma Condensed Combined Financial Information

EX-99.2 3 ex992.htm EXHIBIT 99.2 HEALTHCARE TRIANGLE, INC. Unaudited Pro Forma Condensed Combined Financial Information On December 10, 2021, Healthcare Triangle, Inc. (the “Company”) entered into a Share Purchase Agreement (the "Share Purchase Agreement") with Devcool, Inc., a California corporation ("Devcool"), Go To Assistance Inc., a California corporation ("Seller"), and Mr. Sandeep Deokule,

Promissory Note, dated December 10, 2021 made to Go To Assistance Inc. (incorporated by reference to Exhibit 10.2 to the Company’s

SECURED PROMISSORY NOTE $2,208,840.96 December 10, 2021 FOR VALUE RECEIVED, Healthcare Triangle, Inc. a Delaware corporation, having its principal place of business at 4309 Hacienda Drive, Suite 150, Pleasanton, CA 94583 (?Buyer?), issues this SECURED PROMISSORY NOTE (this ?Note?) to Go To Assistance Inc., a California corporation, having its principal place of business at 1217 Pineto Place, Pleas

Healthcare Triangle (HCTI) Acquires DevCool, an Electronic Health Record (EHR) Focused Healthcare IT and Managed Services Company Acquisition Expected to Add Approximately $20 Million in Revenues

EX-99.1 5 ex991.htm EXHIBIT 99.1 Healthcare Triangle (HCTI) Acquires DevCool, an Electronic Health Record (EHR) Focused Healthcare IT and Managed Services Company Acquisition Expected to Add Approximately $20 Million in Revenues PLEASANTON, Calif., December 13, 2021— Healthcare Triangle, Inc. (HCTI), a leading provider of Healthcare and Life Sciences cloud transformation, managed services and data

Share Purchase Agreement, dated December 10, 2021, among Healthcare Triangle, Inc., Devcool, Inc., Go To Assistance Inc., and Mr. Sandeep Deokule(2)

EX-10.1 2 ex101.htm EXHIBIT 10.1 SHARE PURCHASE AGREEMENT This SHARE PURCHASE AGREEMENT (this “Agreement”) dated as of December 10, 2021 (the “Execution Date”), is entered into by and among: (a) Devcool, Inc., a California corporation (the “Company”); (b) Go To Assistance Inc., a California corporation and the sole shareholder of the Company (the “Seller”); (c) Mr. Sandeep Deokule, an individual a

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 10, 2021 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of incorporation) (Commis

Consulting Agreement dated December 10, 2021 between the Company and Sandeep Deokule (incorporated by reference to Exhibit 10.3 to

EX-10.3 4 ex103.htm EXHIBIT 10.3 SECURITY AGREEMENT This SECURITY AGREEMENT (this “Agreement”), dated as of December 10, 2021, is entered into by and between Healthcare Triangle, Inc. a Delaware corporation, having its principal place of business at 4309 Hacienda Drive, Suite 150, Pleasanton, CA 94583 (“Buyer”), and Go To Assistance Inc., a California corporation, having its principal place of bus

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment #1 ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ☐ TRANSITION

10-Q/A 1 hcti093021form10qa.htm 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment #1 ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ☐ TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40903 HEALTHCARE TRIANGLE,

Equity Purchase Agreement, dated May 8, 2020 between the Registrant and SecureKloud Technologies, Inc.

Exhibit 10.2 HEALTHCARE TRIANGLE, INC. EQUITY PURCHASE AGREEMENT This Equity Purchase Agreement (this ?Agreement?) is made and entered into as of May 8, 2020 (the ?Effective Date?) between Healthcare Triangle, Inc., a Delaware corporation (the ?Purchaser?) and 8K Miles Software Services Inc., a Nevada corporation (?Seller?). The parties agree as follows: 1. Sale of Equity and Consideration. 1.1 In

Master Services Agreement dated January 1, 2020 between the Registrant and SecureKloud Technologies, Inc.

EX-10.8 4 ex108.htm EXHIBIT 3 Exhibit 10.8 HEALTHCARE TRIANGLE INC. MASTER SERVICES AGREEMENT THIS Master Services Agreement (the “Agreement”) is entered into as of 01 January, 2020 (the “Effective Date”) by and between by and between Healthcare Triangle Inc., a Nevada corporation having its principal place of business 4309 Hacienda Dr, Suite 150, Pleasanton, CA 94588, (the “Company”) and 8K Miles

Asset Transfer Agreement, dated January 1, 2020 between the Registrant and SecureKloud Technologies, Inc.

Exhibit 10.1 ASSET TRANSFER AGREEMENT JANUARY 1, 2020 1 ASSET TRANSFER AGREEMENT This ASSET TRANSFER AGREEMENT (the ?Agreement?) is entered into as of January 1, 2020 (?Execution Date?) by and between: (1) 8K Miles Software Services Inc., a Nevada corporation, having its registered office at 4309 Hacienda Drive, Suite 150, Pleasanton, CA 94588 (the ?Seller? which expression shall unless repugnant

Shared Services Agreement dated January 1, 2020 between the Registrant and SecureKloud Technologies, Inc.

Exhibit 10.9 HEALTHCARE TRIANGLE INC. SHARED SERVICES AGREEMENT This SHARED SERVICES AGREEMENT (the ?Agreement?), is entered into on January 1, 2020 (the ?Effective Date?), by and between 8K Miles Software Services Inc., a Nevada corporation (the ?8K Miles?) and Healthcare Triangle Inc., a Nevada corporation, (the ?Company?). 8K Miles and the Company are hereinafter sometimes referred to collectiv

Rental Sublease Agreement dated January 4, 2020 between SecureKloud Technologies, Inc. and the Registrant.

EX-10.10 6 ex1010.htm EXHIBIT 5 Exhibit 10.10 Rental Sub-Lease Agreement 8K Miles Software Services, Inc. This Rental Sub-Lease Agreement (this “Sub-Lease Agreement”) is made and entered into effect as of January 4th, 2020 by and between 8K Miles Software Services, Inc. (“Tenant”) and Health Care Triangle, Inc. (“Sub-Tenant”), based on the master lease agreement between the tenant and the landlord

DE:4MR / Healthcare Triangle Inc / SECUREKLOUD TECHNOLOGIES, INC. - SC 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No.

DE:4MR / Healthcare Triangle Inc / SECUREKLOUD TECHNOLOGIES, INC. - SC 13D Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No.

Form of Underwriter’s Warrant (incorporated by reference to Exhibit 4.1 to the Company’s Registration Statement No. 333-259180, initially filed on August 30, 2021)

EX-4.1 3 ex41.htm EXHIBIT 4.1 Representative’s Warrant Agreement THE REGISTERED HOLDER OF THIS PURCHASE WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS PURCHASE WARRANT EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS PURCHASE WARRANT AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR HYPOTHECATE THIS PURCHASE WARRANT FOR A PERIOD OF ONE HU

Entry into a Material Definitive Agreement, Other Events, Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 12, 2021 HEALTHCARE TRIANGLE, INC. (Exact name of registrant as specified in its charter) Delaware 001-40903 84-3559776 (State or other jurisdiction of Incorporation) (Commiss

Healthcare Triangle, Inc. Announces Pricing of $13.0 Million Initial Public Offering

EX-99.1 4 ex991.htm EXHIBIT 99.1 Exhibit 99.1 Healthcare Triangle, Inc. Announces Pricing of $13.0 Million Initial Public Offering October 12, 2021 19:44 ET | Source: Healthcare Triangle, Inc. PLEASANTON, Calif., Oct. 12, 2021 (GLOBE NEWSWIRE) - Healthcare Triangle, Inc. ("HTI" or the "Company"), a leader in the public cloud for Hospitals, Health Systems and Life Sciences today announced the prici

Underwriting Agreement dated October 12, 2021.

UNDERWRITING AGREEMENT between HEALTHCARE TRIANGLE, INC. and EF HUTTON division of Benchmark Investments, LLC, as Representative of the Several Underwriters HEALTHCARE TRIANGLE, INC. UNDERWRITING AGREEMENT New York, New York October 12, 2021 EF Hutton, division of Benchmark Investments, LLC as Representative of the several Underwriters named on Schedule 1 hereto 590 Madison Avenue, 39th Floor New

Healthcare Triangle, Inc. Announces Closing of $13.0 Million Initial Public Offering

EX-99.2 5 ex992.htm EXHIBIT 99.2 Exhibit 99.2 Healthcare Triangle, Inc. Announces Closing of $13.0 Million Initial Public Offering October 15, 2021 19:44 ET | Source: Healthcare Triangle, Inc. PLEASANTON, Calif., Oct. 15, 2021 (GLOBE NEWSWIRE) - Healthcare Triangle, Inc. ("HTI" or the "Company"), a leader in the public cloud for Hospitals, Health Systems and Life Sciences today announced the closi

PROSPECTUS HEALTHCARE TRIANGLE, INC. 4,709,255 Shares of Common Stock

424B4 1 hcti101421form424b4.htm 424B4 Filed Pursuant to Rule 424(b)(4) Registration No. 333-259180 PROSPECTUS HEALTHCARE TRIANGLE, INC. 4,709,255 Shares of Common Stock This is an initial public offering of shares of common stock, par value $0.00001 per share, of Healthcare Triangle, Inc., or the Company. We are offering 3,262,500 shares of our common stock, and the selling stockholders identified

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934

8-A12B 1 hcti101221form8a.htm 8-A12B UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 Healthcare Triangle, Inc. (Exact name of registrant as specified in its charter) Delaware 84-3559776 (State or other jurisdiction of incorporation) (IRS Employe

EF Hutton, Division of Benchmark Investments, LLC 590 Madison Avenue, 39th Floor New York, NY 10022

CORRESP 1 filename1.htm EF Hutton, Division of Benchmark Investments, LLC 590 Madison Avenue, 39th Floor New York, NY 10022 October 8, 2021 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 Attention: Ms. Anna Abramson Re: Healthcare Triangle, Inc Registration Statement on Form S-1, as amended File No. 333- 259180 Dear Ms. Abr

Ladies and Gentlemen:

Healthcare Triangle, Inc. 4309 Hacienda Dr., Suite 150 Pleasanton, CA 94588 October 8, 2021 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Ms. Anna Abramson Re: Healthcare Triangle, Inc. Registration Statement on Form S-1, as amended File No. 333- 259180 Ladies and Gentlemen: Pursuant to Rules 460 and

As filed with the Securities and Exchange Commission on October 8, 2021

S-1/A 1 hti100821forms1a.htm S-1/A As filed with the Securities and Exchange Commission on October 8, 2021 Registration No. 333-259180 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Pre-Effective Amendment No. 5 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Healthcare Triangle, Inc. (Exact name of registrant as specified in its charter) Delaware 7373

As filed with the Securities and Exchange Commission on October 7, 2021

S-1/A 1 hti100621forms1a.htm S-1/A As filed with the Securities and Exchange Commission on October 7, 2021 Registration No. 333-259180 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Pre-Effective Amendment No. 4 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Healthcare Triangle, Inc. (Exact name of registrant as specified in its charter) Delaware 7373

Form of Representative’s Warrant(1)

UNDERWRITING AGREEMENT between HEALTHCARE TRIANGLE, INC. and EF HUTTON division of Benchmark Investments, LLC, as Representative of the Several Underwriters HEALTHCARE TRIANGLE, INC. UNDERWRITING AGREEMENT New York, New York [?], 2021 EF Hutton, division of Benchmark Investments, LLC as Representative of the several Underwriters named on Schedule 1 hereto 590 Madison Avenue, 39th Floor New York, N

EF Hutton, Division of Benchmark Investments, LLC 590 Madison Avenue, 39th Floor New York, NY 10022

CORRESP 1 filename1.htm EF Hutton, Division of Benchmark Investments, LLC 590 Madison Avenue, 39th Floor New York, NY 10022 October 6, 2021 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 Attention: Ms. Anna Abramson Re: Healthcare Triangle, Inc. Registration Statement on Form S-1, as amended File No. 333- 259180 Dear Ms. Ab

Ladies and Gentlemen:

CORRESP 1 filename1.htm Healthcare Triangle, Inc. 4309 Hacienda Dr., Suite 150 Pleasanton, CA 94588 October 6, 2021 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Ms. Anna Abramson Re: Healthcare Triangle, Inc. Registration Statement on Form S-1, as amended File No. 333- 259180 Ladies and Gentlemen: Re

Ladies and Gentlemen:

CORRESP 1 filename1.htm Healthcare Triangle, Inc. 4309 Hacienda Dr., Suite 150 Pleasanton, CA 94588 October 4, 2021 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Ms. Anna Abramson Re: Healthcare Triangle, Inc. Registration Statement on Form S-1, as amended File No. 333- 259180 Ladies and Gentlemen: Pu

EF Hutton, Division of Benchmark Investments, LLC 590 Madison Avenue, 39th Floor New York, NY 10022

EF Hutton, Division of Benchmark Investments, LLC 590 Madison Avenue, 39th Floor New York, NY 10022 October 4, 2021 VIA EDGAR U.

Consulting Agreement dated December 18, 2020, Between the Company and Alchemy Advisors LLC

EX-10.19 8 ex1019.htm EXHIBIT 10.19 CONSULTING AGREEMENT This Consulting Agreement (the "Agreement") is entered into as of this 18th day of December, 2020 (the "Effective Date"), by and between Alchemy Advisory LLC, a Limited Liability Company organized under the laws of Puerto Rico (the "Consultant") and located at 13600 CaiT 968, Apt 64, Rio Grande, PR 00745 and Healthcare Triangle, Inc., a Dela

As filed with the Securities and Exchange Commission on September 30, 2021

S-1/A 1 hti092921forms1a.htm S-1/A As filed with the Securities and Exchange Commission on September 30, 2021 Registration No. 333-259180 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 3 To FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Healthcare Triangle, Inc. (Exact name of registrant as specified in its charter) Delaware 7373 84-3559776

Leak-Out Agreement dated September 27, 2021 between Target Capital, LLC and the Company

EX-10.18 6 ex1018.htm EXHIBIT 10.18 Form of Leak-Out Agreement September 27, 2021 EF Hutton Division of Benchmark Investments, LLC 590 Madison Avenue, 39th Floor New York, NY 10022 Ladies and Gentlemen: This Leak-Out Agreement (the “Leak-Out Agreement”) is being delivered to you in connection with the underwriting agreement (the “Underwriting Agreement”) to be entered into by Healthcare Triangle,

Form of Common Stock Purchase Warrant to be issued to the Placement Agent for the Note and Warrant Private Offering

EX-10.16 4 ex1016.htm EXHIBIT 10.16 HEALTHCARE TRIANGLE, INC. 2020 STOCK INCENTIVE PLAN ARTICLE 1 ESTABLISHMENT, OBJECTIVES, AND DURATION 1.1 Establishment of the Plan. Healthcare Triangle, Inc., hereby establishes an incentive compensation plan to be known as the “Healthcare Triangle, Inc. 2020 Omnibus Incentive Plan” (hereinafter referred to as the “Plan”). The Plan permits the granting of Nonqu

As filed with the Securities and Exchange Commission on September 27, 2021

S-1/A 1 hti092321forms1a.htm S-1/A As filed with the Securities and Exchange Commission on September 27, 2021 Registration No. 333-259180 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 2 To FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Healthcare Triangle, Inc. (Exact name of registrant as specified in its charter) Delaware 7373 84-3559776

Leak-Out Agreement dated September 27, 2021 between Alchemy Advisor, LLC and the Company

EX-10.17 5 ex1017.htm EXHIBIT 10.17 Form of Leak-Out Agreement September 27, 2021 EF Hutton Division of Benchmark Investments, LLC 590 Madison Avenue, 39th Floor New York, NY 10022 Ladies and Gentlemen: This Leak-Out Agreement (the “Leak-Out Agreement”) is being delivered to you in connection with the underwriting agreement (the “Underwriting Agreement”) to be entered into by Healthcare Triangle,

Form of Underwriter’s Warrant (incorporated by reference to Exhibit 4.1 to the Company’s Registration Statement No. 333-259180, initially filed on August 30, 2021)

UNDERWRITING AGREEMENT between HEALTHCARE TRIANGLE, INC. and EF HUTTON division of Benchmark Investments, LLC, as Representative of the Several Underwriters HEALTHCARE TRIANGLE, INC. UNDERWRITING AGREEMENT New York, New York [●], 2021 EF Hutton, division of Benchmark Investments, LLC as Representative of the several Underwriters named on Schedule 1 hereto 17 Battery Place, Suite 625 New York, New

Division of Corporation Finance

Division of Corporation Finance U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Healthcare Triangle, Inc. Amendment No.1 to Registration Statement on Form S-1 Filed September 10, 2021 File No. 333-259180 Dear Staff: On behalf of Healthcare Triangle, Inc. (the ?Company?), we have set forth below responses to the comments of the staff (the ?Staff?) of the U.S. S

LETTER

United States securities and exchange commission logo September 15, 2021 Suresh Venkatachari Chief Executive Officer Healthcare Triangle, Inc.

Series A Preferred Stock Amended and Restated Certificate of Designations

State of Delaware Secretary of State Division of Corporatoins Delivered 01:25 PM 09/10/2021 FILED 01:25 PM 09/10/2021 SR 20213214262 - File Number 7949634 HEALTHCARE TRIANGLE, INC.

September 10, 2021

CORRESP 1 filename1.htm September 10, 2021 Division of Corporation Finance U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Healthcare Triangle, Inc. Registration Statement on Form S-1 Filed August 30, 2021 File No. 333-259180 Dear Staff: On behalf of Healthcare Triangle, Inc. (the “Company”), we have set forth below responses to the comments of the staff (the

As filed with the Securities and Exchange Commission on September 10, 2021

As filed with the Securities and Exchange Commission on September 10, 2021 Registration No.

Healthcare Triangle, Inc. Revolutionizing Healthcare Through Innovation September 8, 2021 ? 2021 Healthcare Triangle, Inc. All rights reserved. Free Writing Prospectus filed pursuant to Rule 433 ; Registration Statement No . 333 - 259180 This present

FWP 1 hti090821fwp.htm FWP Healthcare Triangle, Inc. Revolutionizing Healthcare Through Innovation September 8, 2021 © 2021 Healthcare Triangle, Inc. All rights reserved. Free Writing Prospectus filed pursuant to Rule 433 ; Registration Statement No . 333 - 259180 This presentation has been prepared by Healthcare Triangle , Inc . (the “Company”) and may contain forward - looking statements as defi

LETTER

United States securities and exchange commission logo September 9, 2021 Suresh Venkatachari Chief Executive Officer Healthcare Triangle, Inc.

Offer letter dated January 1, 2020 between the Registrant and Sudish Mogli

Exhibit 10.11 HEALTHCARE TRIANGLE INC. 4309 Hacienda Dr, Suite 150, Pleasanton, CA 94588 January 1, 2020 Sudish Mogli 3943, Soutirage ln , San Jose , CA 95135 Email: [email protected] Dear Sudish , Healthcare Triangle Inc., a Nevada corporation (the “Company”), is pleased to offer you employment with the Company on the terms described below. 1. Position. You will start in a full-time position as

Asset Transfer Agreement, dated January 1, 2020 between the Registrant and SecureKloud Technologies, Inc.

Exhibit 10.1 ASSET TRANSFER AGREEMENT JANUARY 1, 2020 1 ASSET TRANSFER AGREEMENT This ASSET TRANSFER AGREEMENT (the ?Agreement?) is entered into as of January 1, 2020 (?Execution Date?) by and between: (1) 8K Miles Software Services Inc., a Nevada corporation, having its registered office at 4309 Hacienda Drive, Suite 150, Pleasanton, CA 94588 (the ?Seller? which expression shall unless repugnant

List of Subsidiaries of the Registrant

EX-21.1 21 ex211.htm EXHIBIT 21.1 Exhibit 21.1 List of Subsidiaries of the Registrant None.

Form of Grant

EX-10.7 12 ex107.htm EXHIBIT 10.7 Exhibit 10.7 Exhibit A HEALTHCARE TRIANGLE, INC. Non-Qualified Stock Option Agreement Section 1. Grant of Option. (a) Option. On the terms and conditions set forth in the Notice of Non-Qualified Stock Option Grant (the “Grant Notice”) and this Stock Option Agreement (the “Agreement”), the Company grants to the Optionee on the Effective Date of Grant the option (th

Form of Statement of Work under Master Services Agreement between F. Hoffmann-La Roche Ltd and the Registrant

Certain identified information has been excluded from this Exhibit 10.15 because it is both not material and is the type that the registrant treats as private or confidential. STATEMENT OF WORK This Statement of Work (?SOW?), effective May 14, 2021, submitted in connection with the Master Service Agreement by and between F. Hoffman La-Roche, Inc. (?Genentech?) and Healthcare Triangle, Inc (?Vendor

Form of Common Stock Securities Purchase Agreement

EMPLOYMENT AGREEMENT AGREEMENT, dated as of July 12, 2021 (the Effective Date") by and between Healthcare Triangle, Inc.

Form of 10% Convertible Promissory Note issued pursuant to the Securities Purchase Agreement

Exhibit 10.4 Appendix B NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFE

Offer letter dated January 1, 2020 between the Registrant and Anand Kumar

Exhibit 10.12 HEALTHCARE TRIANGLE INC. 4309 HACIENDA DR, SUITE 150 PLEASANTON, CA 94588 January 1, 2020 Anand Kumar 3505 Carlisle ln Carpentersville, IL 60110 Email: [email protected] Dear Anand Kumar, Healthcare Triangle Inc., a Nevada corporation (the “Company”), is pleased to offer you employment with the Company on the terms described below. 1. Position. You will start in a full-time position as

Form of Common Stock Purchase Warrant issued pursuant to the Securities Purchase Agreement

Exhibit 10.5 Appendix C NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFEC

Bylaws of the Company(1)

EX-3.2 3 ex32.htm EXHIBIT 3.2 Exhibit 3.2 BYLAWS OF HEALTHCARE TRIANGLE, INC. 1 TABLE OF CONTENTS Page ARTICLE I CORPORATE OFFICES 1 1.1 Offices 1 ARTICLE II MEETINGS OF STOCKHOLDERS 1 2.1 Place of Meetings 1 2.2 Annual Meeting 1 2.3 Special Meeting 1 2.4 Notice of Stockholders’ Meetings 2 2.5 Manner of Giving Notice; Affidavit of Notice 2 2.6 Quorum 2 2.7 Adjourned Meeting; Notice 2 2.8 Organizat

IT Master Services Agreement effective as of May 1, 2017 between F. Hoffmann-La Roche Ltd and the Company(1)

EX-10.14 17 ex1014.htm EXHIBIT 10.14 IT Master Procurement Agreement (Ref.: MPA # 8KMilesMPA20170512) Between 8KMiles Software Services, Inc. 12647 Alcosta Blvd., San Ramon, CA 94583 (hereinafter called “Supplier” or “Licensor”) And F. Hoffmann-La Roche Ltd Grenzacherstrasse 124, CH-4070 Basel Switzerland (hereinafter called "Buyer" or “Roche”) By signing below, the Parties agree to enter into the

Shared Services Agreement dated January 1, 2020 between the Company and SecureKloud Technologies, Inc.(1)

EX-10.9 14 ex109.htm EXHIBIT 10.9 Exhibit 10.9 HEALTHCARE TRIANGLE INC. SHARED SERVICES AGREEMENT This SHARED SERVICES AGREEMENT (the “Agreement”), is entered into on January 1, 2020 (the “Effective Date”), by and between 8K Miles Software Services Inc., a Nevada corporation (the “8K Miles”) and Healthcare Triangle Inc., a Nevada corporation, (the “Company”). 8K Miles and the Company are hereinaft

Series A Preferred Stock Certificate of Designation

EX-3.4 7 ex34.htm EXHIBIT 3.4 Delaware The First State I, JEFFREY W. BULLOCK, SECRETARY OF STATE OF THE STATE OF DELAWARE, DO HEREBY CERTIFY THE ATTACHED IS A TRUE AND CORRECT COPY OF THE CERTIFICATE OF DESIGNATION OF “HEALTHCARE TRIANGLE, INC.”, FILED IN THIS OFFICE ON THE THIRTEENTH DAY OF AUGUST, A.D. 2021, AT 7:40 O`CLOCK P.M. 1 State of Delaware Secretary of State Division of Corporations Del

Master Services Agreement dated January 1, 2020 between the Company and SecureKloud Technologies, Inc.(1)

EX-10.8 13 ex108.htm EXHIBIT 10.8 Exhibit 10.8 HEALTHCARE TRIANGLE INC. MASTER SERVICES AGREEMENT THIS Master Services Agreement (the “Agreement”) is entered into as of 01 January, 2020 (the “Effective Date”) by and between by and between Healthcare Triangle Inc., a Nevada corporation having its principal place of business 4309 Hacienda Dr, Suite 150, Pleasanton, CA 94588, (the “Company”) and 8K M

August 30, 2021

CORRESP 1 filename1.htm August 30, 2021 Division of Corporation Finance Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Healthcare Triangle, Inc. Draft Registration Statement on Form S-1 Submitted June 24, 2021 CIK No. 0001839285 Dear Staff: On behalf of Healthcare Triangle, Inc. (the “Company”), we have set forth below responses to the comments of the staff (the “

As filed with the Securities and Exchange Commission on August 30, 2021

S-1 1 hti081821forms1.htm S-1 As filed with the Securities and Exchange Commission on August 30, 2021 Registration No. 333-[●] UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 healthcare Triangle, Inc. (Exact name of registrant as specified in its charter) Delaware 7373 84-3559776 (State or other jurisdiction o